Responses
Oncolytic and local immunotherapy
Original research
Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.